These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28214355)

  • 1. An enhanced recombinant amino-terminal acetylation system and novel in vivo high-throughput screen for molecules affecting α-synuclein oligomerisation.
    Eastwood TA; Baker K; Brooker HR; Frank S; Mulvihill DP
    FEBS Lett; 2017 Mar; 591(6):833-841. PubMed ID: 28214355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Expression and Purification of N-Acetylated Alpha-Synuclein.
    Eastwood TA; Mulvihill DP
    Methods Mol Biol; 2019; 1948():113-121. PubMed ID: 30771174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of recombinant tetrameric N-acetylated α-synuclein.
    Fernández RD; Lucas HR
    Protein Expr Purif; 2018 Dec; 152():146-154. PubMed ID: 30041032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Terminal Acetylation Preserves α-Synuclein from Oligomerization by Blocking Intermolecular Hydrogen Bonds.
    Bu B; Tong X; Li D; Hu Y; He W; Zhao C; Hu R; Li X; Shao Y; Liu C; Zhao Q; Ji B; Diao J
    ACS Chem Neurosci; 2017 Oct; 8(10):2145-2151. PubMed ID: 28741930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of amino-terminally acetylated recombinant proteins in E. coli.
    Johnson M; Geeves MA; Mulvihill DP
    Methods Mol Biol; 2013; 981():193-200. PubMed ID: 23381863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pTSara-NatB, an improved N-terminal acetylation system for recombinant protein expression in E. coli.
    Rovere M; Powers AE; Patel DS; Bartels T
    PLoS One; 2018; 13(7):e0198715. PubMed ID: 29995905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of semisynthetic and naturally Nα-acetylated α-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of α-synuclein.
    Fauvet B; Fares MB; Samuel F; Dikiy I; Tandon A; Eliezer D; Lashuel HA
    J Biol Chem; 2012 Aug; 287(34):28243-62. PubMed ID: 22718772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational ensemble of human α-synuclein physiological form predicted by molecular simulations.
    Rossetti G; Musiani F; Abad E; Dibenedetto D; Mouhib H; Fernandez CO; Carloni P
    Phys Chem Chem Phys; 2016 Feb; 18(8):5702-6. PubMed ID: 26553504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Terminal acetylation is critical for forming α-helical oligomer of α-synuclein.
    Trexler AJ; Rhoades E
    Protein Sci; 2012 May; 21(5):601-5. PubMed ID: 22407793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for N-terminal alpha-synuclein acetylation by human NatB.
    Deng S; Pan B; Gottlieb L; Petersson EJ; Marmorstein R
    Elife; 2020 Sep; 9():. PubMed ID: 32885784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation of alpha-synuclein expressed in Escherichia coli.
    Ren G; Wang X; Hao S; Hu H; Wang CC
    J Bacteriol; 2007 Apr; 189(7):2777-86. PubMed ID: 17277073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductive modification of genetically encoded 3-nitrotyrosine sites in alpha synuclein expressed in E.coli.
    Gerding HR; Karreman C; Daiber A; Delp J; Hammler D; Mex M; Schildknecht S; Leist M
    Redox Biol; 2019 Sep; 26():101251. PubMed ID: 31226647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State.
    Kurnik M; Sahin C; Andersen CB; Lorenzen N; Giehm L; Mohammad-Beigi H; Jessen CM; Pedersen JS; Christiansen G; Petersen SV; Staal R; Krishnamurthy G; Pitts K; Reinhart PH; Mulder FAA; Mente S; Hirst WD; Otzen DE
    Cell Chem Biol; 2018 Nov; 25(11):1389-1402.e9. PubMed ID: 30197194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.
    Yamaguchi Y; Masuda M; Sasakawa H; Nonaka T; Hanashima S; Hisanaga S; Kato K; Hasegawa M
    J Mol Biol; 2010 Jan; 395(3):445-56. PubMed ID: 19895818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the effects of N-terminal acetylation on α-synuclein structure, aggregation and cytotoxicity.
    Bell R; Vendruscolo M; Kumita JR
    Methods Enzymol; 2023; 686():45-65. PubMed ID: 37532408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-content analysis of α-synuclein aggregation and cell death in a cellular model of Parkinson's disease.
    Macchi F; Deleersnijder A; Van den Haute C; Munck S; Pottel H; Michiels A; Debyser Z; Gerard M; Baekelandt V
    J Neurosci Methods; 2016 Mar; 261():117-27. PubMed ID: 26620202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
    Schnack C; Danzer KM; Hengerer B; Gillardon F
    Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds.
    Caruana M; Högen T; Levin J; Hillmer A; Giese A; Vassallo N
    FEBS Lett; 2011 Apr; 585(8):1113-20. PubMed ID: 21443877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies.
    Moussaud S; Malany S; Mehta A; Vasile S; Smith LH; McLean PJ
    Expert Opin Ther Targets; 2015 May; 19(5):589-603. PubMed ID: 25785645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway.
    Giehm L; Oliveira CL; Christiansen G; Pedersen JS; Otzen DE
    J Mol Biol; 2010 Aug; 401(1):115-33. PubMed ID: 20540950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.